// App-Quantinova.ai

2946 : Incidence Rate Of Venous Thromboembolism (VTE) and Utilization Of a VTE Prophylaxis Order Set Module In Hospitalized Patients With Leukemia

Researchers

Presenter

  • Michael H. Kroll

Principal Investigators

  • Alessandra Ferrajoli

  • Lee Cheng

  • Jack L Watkins

  • Maria Alma Rodriguez

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic myelomonocytic leukemia

  • Chronic Lymphocytic Leukemia

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Venous thrombosis

  • Acute myelocytic leukemia

  • Deep vein thrombosis

  • Pulmonary embolism

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved